Bidencare, a boost for Indian pharmaceutical companies

The Indian pharma sector is expected to benefit from the Biden presidency on the back of an increased push for generic prescriptions and access to affordable health insurance.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/32toTv3
via IFTTT